Eduardo Núñez-rekin lankidetzan egindako argitalpenak (59)

2023

  1. Risk of death associated with incident heart failure in patients with known or suspected chronic coronary syndrome

    ESC Heart Failure, Vol. 10, Núm. 1, pp. 264-273

2022

  1. Carbohydrate antigen 125 and risk of heart failure readmissions in patients with heart failure and preserved ejection fraction

    Scientific Reports, Vol. 12, Núm. 1

  2. Magnetic Resonance Assessment of Left Ventricular Ejection Fraction at Any Time Post-Infarction for Prediction of Subsequent Events in a Large Multicenter STEMI Registry

    Journal of Magnetic Resonance Imaging, Vol. 56, Núm. 2, pp. 476-487

2021

  1. Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review

    European Journal of Heart Failure, Vol. 23, Núm. 9, pp. 1445-1457

  2. Early urinary sodium trajectory and risk of adverse outcomes in acute heart failure and renal dysfunction

    Revista Espanola de Cardiologia, Vol. 74, Núm. 7, pp. 616-623

  3. Homocysteine and long-term recurrent infarction following an acute coronary syndrome

    Cardiology Journal, Vol. 28, Núm. 4, pp. 598-606

  4. Right ventricular function and iron deficiency in acute heart failure

    European Heart Journal: Acute Cardiovascular Care, Vol. 10, Núm. 4, pp. 406-414

  5. Sex differences in mortality in stable patients undergoing vasodilator stress cardiovascular magnetic resonance

    Open Heart, Vol. 8, Núm. 1

  6. Sex differences on new-onset heart failure in patients with known or suspected coronary artery disease

    European journal of preventive cardiology, Vol. 28, Núm. 15, pp. 1711-1719

2020

  1. CA125 outperforms NT-proBNP in acute heart failure with severe tricuspid regurgitation

    International Journal of Cardiology, Vol. 308, pp. 54-59

  2. Differential prognostic impact of type 2 diabetes mellitus in women and men with heart failure with preserved ejection fraction

    Revista Espanola de Cardiologia, Vol. 73, Núm. 6, pp. 463-470

  3. Effect of insulin on readmission for heart failure following a hospitalization for acute heart failure

    ESC Heart Failure, Vol. 7, Núm. 6, pp. 3320-3328

  4. Factors associated with plasma antigen carbohydrate 125 and amino-terminal pro-B-type natriuretic peptide concentrations in acute heart failure

    European Heart Journal: Acute Cardiovascular Care, Vol. 9, Núm. 5, pp. 437-447

  5. Relation of Low Lymphocyte Count to Frailty and its Usefulness as a Prognostic Biomarker in Patients >65 Years of Age With Acute Coronary Syndrome

    American Journal of Cardiology, Vol. 125, Núm. 7, pp. 1033-1038

  6. Role of PCSK9 in the course of ejection fraction change after ST-segment elevation myocardial infarction: a pilot study

    ESC Heart Failure, Vol. 7, Núm. 1, pp. 117-122

2019

  1. Functional tricuspid regurgitation and recurrent admissions in patients with acute heart failure

    International Journal of Cardiology, Vol. 291, pp. 83-88

2018

  1. Heart rate response and functional capacity in patients with chronic heart failure with preserved ejection fraction

    ESC Heart Failure, Vol. 5, Núm. 4, pp. 579-585

  2. Intrarenal venous flow in cardiorenal syndrome: a shining light into the darkness

    ESC Heart Failure, Vol. 5, Núm. 6, pp. 1173-1175

  3. Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality

    Circulation, Vol. 137, Núm. 13, pp. 1320-1330

  4. Peak Exercise Oxygen Uptake Predicts Recurrent Admissions in Heart Failure With Preserved Ejection Fraction

    Revista Espanola de Cardiologia, Vol. 71, Núm. 4, pp. 250-256